TL;DR: Convexia is a Y Combinator Summer 2025 startup The world's first AI-maximalist pharma company, currently active with a team of 4.
The world's first AI-maximalist pharma company
Last verified:
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates. Scientific Agent: Runs comp bio models (ESM-3, RFdiffusion, Boltz-2, AlphaFold) to assess safety and efficacy in silico. Commercial Agent: Analyzes FDA incentives, pricing dynamics, TAM, competitive landscape, and payer alignment. Clinical Agent: Runs digital twin simulations, evaluates CRO/CMC risk, and builds trial plans to Phase 1. PoS Agent: Evaluates the most critical factors that impact the likelihood of clinical trial success. Built by 2 Stanford CS students who have built 3 startups together before.
Built by LemStudio
Yes. Convexia was funded by Y Combinator in the Summer 2025 batch. The world's first AI-maximalist pharma company
An AI-maximalist pharma platform. We use agents to buy drugs, run clinical trials, and sell for a profit. 10x faster and 20x leaner than incumbents. Sourcing Agent: Mines public/private databases and unstructured global data to surface overlooked preclinical candidates. Scientific Agent: Runs comp bio models (ESM-3, R…
Convexia was part of Y Combinator's Summer 2025 batch.
Convexia has a team of 4 people according to Y Combinator's directory.
Convexia is currently listed as Active with a team of 4 in Y Combinator's directory.
Loading interactive view…